首页> 美国卫生研究院文献>other >An Enteric Pathogen Salmonella enterica serovar Typhimurium Suppresses Tumor Growth by Down Regulating CD44high and CD4 T Regulatory (Treg) Cell Expression in Mice: Critical Role of Lipopolysaccharide and Braun Lipoprotein in Modulating Tumor Growth
【2h】

An Enteric Pathogen Salmonella enterica serovar Typhimurium Suppresses Tumor Growth by Down Regulating CD44high and CD4 T Regulatory (Treg) Cell Expression in Mice: Critical Role of Lipopolysaccharide and Braun Lipoprotein in Modulating Tumor Growth

机译:肠道病原体沙门氏菌肠道肠道毒蕈氏菌抑制在小鼠中调节CD44High和CD4 T调节(Treg)细胞表达抑制肿瘤生长:脂多糖和Braun脂蛋白在调节肿瘤生长中的关键作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An anti-tumor activity associated with several bacterial pathogens, including Salmonella enterica serovar Typhimurium, has been reported; however, the underlying immunological mechanism(s) that leads to an anti-tumor effect is currently unclear. Further, such pathogens cannot be used to suppress tumor growth because of their potential for causing sepsis. Recently, we reported the characterization of S. Typhimurium isogenic mutants from which the Braun lipoprotein genes (lppA and B) and the multicopy repressor of high temperature requirement (msbB) gene were deleted. In a mouse infection model, two mutants, namely, lppB/msbB and lppAB/msbB, minimally induced proinflammatory cytokine production at high doses and were non-lethal to animals. We demonstrated that immunization of mice with these mutants, followed by challenge with the wild-type S. Typhimurium could significantly suppress tumor growth, as evidenced by an 88% regression in tumor size in lppB/msbB mutant-immunized animals over a 24-day period. However, the lppAB/msbB mutant alone was not effective in modulating tumor growth in mice, while the lppB/msbB mutant alone caused marginal regression in tumor size. Importantly, we demonstrated that CD44+ cells grew much faster than CD44 cells from human liver tumors in mice, leading us to examine the possibility that S. Typhimurium might down-regulate CD44 in tumors and splenocytes of mice. Consequently, we found in S. Typhimurium-infected mice that tumor size regression could indeed be related to the down-regulation of CD44high and CD4+CD25+ Treg cells. Importantly, the role of lipopolysaccharide and Braun lipoprotein was critical in S. Typhimurium induced-anti-tumor immune responses. Taken together, we have defined new immune mechanisms leading to tumor suppression in mice by S. Typhimurium.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号